PharmTech Talk

Jan 30, 2015
By PharmTech Editors
CPhI experts make predictions on pharma trends for 2015.
Pharmaceutical Technology: Jan 28, 2015
Industry voices concerns over draft legislation that seeks to get much needed treatments to patients.
Jan 08, 2015
An FDA expert committee has recommend approval of Zarizio, the first US biosimilar application from Sandoz, setting a milestone for generic biologic drugs and setting the stage for future approvals.
PTSM: Pharmaceutical Technology Sourcing and Management: Dec 22, 2014
FDA set several milestones in approving more new, important drugs and biologics in 2014. Breakthrough drug designations went through through the roof, speeding more new therapies for cancer and critical conditions to patients.
Pharmaceutical Technology: Dec 19, 2014
FDA has scheduled a public meeting in early January to assess and weigh data on the first United States application for a biosimilar therapy.
Pharmaceutical Technology Europe: Dec 18, 2014
A global framework of standards enabling collaboration among industry stakeholders is needed to battle the increasing threat of counterfeit medicines.
Pharmaceutical Technology: Dec 16, 2014
Patient access to critical experimental medicines continues to grab public attention as states enact “Right-to-Try” laws and Congress eyes establishing a national policy to provide not-yet-approved therapies to terminally ill patients.
Pharmaceutical Technology: Dec 15, 2014
The development and approval of new vaccines and antivirals to contain and treat the Ebola virus outbreak has become a top priority for the federal government and Congress, as seen in new policies to spur R&D and added funding for these efforts.
Pharmaceutical Technology: Dec 14, 2014
The author looks at how life-science research has evolved in Europe and the United Kingdom, and discusses the current funding opportunities for SMEs.
Pharmaceutical Technology: Dec 01, 2014
Sponsor response to FDA's breakthrough program has exceeded FDA expectations, but puts pressure on manufacturers to address formulation, stability and quality production issues very early in development.